0001689813-19-000130.txt : 20191220 0001689813-19-000130.hdr.sgml : 20191220 20191220214008 ACCESSION NUMBER: 0001689813-19-000130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191218 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AGUIAR ERIC CENTRAL INDEX KEY: 0001262325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 191303316 MAIL ADDRESS: STREET 1: 888 7TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 wf-form4_157689598816947.xml FORM 4 X0306 4 2019-12-18 0 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001262325 AGUIAR ERIC C/O AISLING CAPITAL LLC 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 1 0 0 0 Employee Stock Option (Right to Buy) 52.13 2019-12-18 4 A 0 12000 0 A 2029-12-18 Common Shares 12000.0 12000 I By Spouse The option became exercisable with respect to 3,000 of the shares underlying the option on the grant date (December 18, 2019), and the remaining 9,000 shares underlying the option vest in three equal installments on December 18, 2020, 2021 and 2022, subject to the optionholder's continuous service with the issuer as of each applicable vesting date. This stock option is held by the reporting person's spouse as an employee of the issuer. /s/ Jim Engelhart, Attorney-in-fact 2019-12-20